Lurbinectedin Clinical Trials
14 recruitingDrug
Phase 29Phase 16Phase 33
Showing 1–14 of 14 trials
Recruiting
Phase 3
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
Leiomyosarcoma
PharmaMar450 enrolled97 locationsNCT06088290
Recruiting
Phase 2
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
AbbVie180 enrolled28 locationsNCT07155174
Recruiting
Phase 2
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Desmoplastic Small Round Cell Tumor
Italian Sarcoma Group20 enrolled1 locationNCT07328425
Recruiting
Phase 1Phase 2
Lurbinectedin in FET-Fused Tumors
Ewing SarcomaPediatric CancerDesmoplastic Small Round Cell Tumor+1 more
Children's Hospital of Philadelphia63 enrolled6 locationsNCT05918640
Recruiting
Phase 2
Study of Trilaciclib and Lurbinectidin
Lung Cancer
UNC Lineberger Comprehensive Cancer Center30 enrolled2 locationsNCT05578326
Recruiting
Phase 2
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Small Cell Carcinoma of the BladderHigh Grade Neuroendocrine Tumors of the Urinary Tract
National Cancer Institute (NCI)45 enrolled1 locationNCT06228066
Recruiting
Phase 1Phase 2
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Relapsed Small Cell Lung CancerRecurrent Small Cell Lung Cancer
VA Office of Research and Development166 enrolled11 locationsNCT06681220
Recruiting
Phase 3
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Daiichi Sankyo540 enrolled230 locationsNCT06203210
Recruiting
Phase 1Phase 2
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Ewing SarcomaRefractory Ewing SarcomaRelapsed Ewing Sarcoma
Jazz Pharmaceuticals60 enrolled15 locationsNCT05734066
Recruiting
Phase 1
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
Ovarian Cancer
M.D. Anderson Cancer Center34 enrolled1 locationNCT05636111
Recruiting
Phase 1
Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
Stage IV Lung Cancer AJCC v8Extensive Stage Lung Small Cell Carcinoma
Emory University22 enrolled3 locationsNCT05244239
Recruiting
Phase 2
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
Lung Cancer
Fox Chase Cancer Center280 enrolled1 locationNCT05800587
Recruiting
Phase 3
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd.180 enrolled1 locationNCT06496048
Recruiting
Phase 1Phase 2
LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
ERLINDA M GORDON40 enrolled1 locationNCT05876715